Nuwellis (NUWE) Short term Debt (2015 - 2016)
Nuwellis (NUWE) reported Short term Debt of $3.9 million for Q2 2016, up 107.81% on a YoY basis from $1.9 million in Q3 2015, and up 1.84% quarter-over-quarter from $3.9 million in Q1 2016.
Nuwellis (NUWE) Short term Debt (2015 - 2016) Analysis & Trends
Nuwellis has reported Short term Debt for 2 years, with the latest figure at $3.9 million in Q2 2016.
- For the quarter ending Q2 2016, Short term Debt rose 107.81% year-over-year to $3.9 million; the trailing twelve-month figure through Jun 2016 stood at $3.9 million (up 107.81% YoY), and the FY2015 full-year result was $3.8 million, changed N/A from the prior year.
- Short term Debt for Q2 2016 stood at $3.9 million, up from $3.9 million in the prior quarter.
- The five-year high for Short term Debt was $3.9 million in Q2 2016, with the low at $705000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Nuwellis | 279,710.00 | -1.80 Mn | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 3.94 Mn |
| Mar 31, 2016 | 3.87 Mn |
| Dec 31, 2015 | 3.80 Mn |
| Sep 30, 2015 | 2.87 Mn |
| Jun 30, 2015 | 1.90 Mn |
| Mar 31, 2015 | 705,000.00 |